Alm. Brand – weekly report on share buybacks In the

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

TC BioPharm Continues to Trade On Nasdaq TC BioPharm (Holdings) PLC, recognized by the ticker symbol TCBP, is actively trading on the Nasdaq Global Select Market. This clinical-stage biotechnology company is notably focused on developing allogeneic gamma-delta T cell therapies, primarily targeting cancer and various other medical conditions. Sustained Trading Activity The...

RaptorVision and Veesion Unite for Retail Excellence In a significant development for the retail industry, RaptorVision and Veesion have announced a global strategic partnership. This collaboration merges Veesion’s advanced concealment detection behavioral analytics with RaptorVision’s AI Event-Based Product Engagement and Integration Platform tailored for the retail...

ADM's Financial Overview for Q2 2025 ADM Aéroports de Montréal has released its financial results for the second quarter of 2025. This comprehensive report encompasses passenger traffic data, revenue figures, and insights into ongoing capital investment projects at YUL Montréal-Trudeau International Airport. Key Highlights of the Q2 Results The second quarter of 2025...

Octopus AIM VCT Announces a Strategic Appointment Octopus AIM VCT plc is thrilled to share the exciting news of David Docherty joining the team as an independent Non-Executive Director. His official start will follow the upcoming Annual General Meeting. This strategic move reflects the company's commitment to enhance its governance and leadership. A Wealth of Experience...

Introducing the Associate in Cyber Risk Management Designation In today's digital age, cyber risks have become one of the most pressing challenges for organizations globally. An alarming number of C-level executives—87% according to a recent survey—acknowledge that their companies are not fully prepared to face potential cyberattacks. Recognizing this critical issue,...